Therapeutic Potential of Natural Killer Cells in Gastric Cancer

Area of Science:

• Immunology and Oncology
• Cancer Research
• Innate Immunity

Background:

• Gastric cancer (GC) presents a significant global health challenge with poor prognosis in advanced stages.
• Natural killer (NK) cells, key lymphocytes in innate immunity, demonstrate a critical role in controlling GC initiation, progression, and metastasis.
• Current therapeutic strategies for GC often yield limited success, highlighting the need for novel treatment approaches.

Purpose of the Study:

• To review recent advancements in understanding the intricate relationship between NK cells and gastric cancer.
• To identify and summarize innovative therapeutic strategies designed to enhance NK cell function against GC.
• To explore the potential of boosting NK cell-mediated antitumor activity for improved GC patient outcomes.

Main Methods:

• Comprehensive literature review of studies focusing on NK cells and gastric cancer.
• Analysis of various therapeutic modalities targeting NK cell activation and expansion.
• Synthesis of data on immunotherapies, including cytokines, adoptive cell therapy, and immune checkpoint inhibitors.

Main Results:

• Increasing NK cell numbers and enhancing their cytotoxic activity show promise in GC patients.
• NK cell adoptive therapy, particularly with expanded NK cells, is a safe and effective method to improve anti-GC cytotoxicity.
• Diverse strategies, including cytokines, immunomodulatory drugs, antibodies, vaccines, and gene therapy, can activate NK cells against GC.

Conclusions:

• NK cells are vital effectors in the immune response against gastric cancer.
• Augmenting NK cell number and function represents a promising therapeutic avenue for GC.
• Continued research into novel strategies for NK cell enhancement holds significant potential for improving GC treatment efficacy.